RE: Analysis of Exsanguinator post20 Mar 2026 17:12
In the October 20, 2025 Operational Update, the Company explicitly stated: The Company has been formally recognised by senior defence leadership as a Tier 1 asset within the UK’s innovation ecosystem. This is a documented regulatory statement, not an assumption.
On December 21, 2025, ALRT confirmed Project Ixian had entered a pre-contract pathway and was in the final stages of contract finalisation at a pace that aligns closely with the accelerated delivery objectives set out in the Strategic Defence Review.
The company has already told the market they are on an accelerated, direct path that moves faster than traditional frameworks.
ALRT is the Sovereign Software Capability Accelerator. Its entire purpose, as stated in the February 17, 2026 RNS, is to provide the integration pathways for AI technologies to reach Defence-ready deployment.
ALRT isn't competing with the 26 companies. It is providing the accredited sovereign cloud (Google GDC) that these companies need to use if they want their AI to handle secret-level data.
Andrew Roughan is being granted 142 million warrants with a final target of 6.9p. A CEO of his stature—who delivered £731m in GVA to the UK—does not accept a warrant-heavy package at 6.9p if he is joining a speculative company. He is joining to execute the contracts he helped architect while at Plexal.
This isn't speculation. It is a direct reading of the Company’s 2025/2026 regulatory filings. We have the Tier 1 status, we have the £2.2m cash, and in 10 days, we have the CEO.